RxDoctor Payments DataLook up a doctor →

Carly Harrington

Adult Health · Amherst, NYNPI 1679151625

Payments from drug & device makers

$23,842in general payments, 2019–2025

Across 1,026 payments — averaging $23.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$9K
  • AbbVie$3K
  • Teva Pharmaceuticals USA, Inc.$1K
  • MDD US Operations, LLC$1K
  • Amgen$996
  • Tonix Medicines, Inc.$886
  • plus $8K from 44 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axsome Therapeutics, Inc.22$8,862
AbbVie170$2,918
Teva Pharmaceuticals USA, Inc.82$1,228
MDD US Operations, LLC35$1,208
Amgen47$996
Tonix Medicines, Inc.77$886
Currax Pharmaceuticals LLC69$778
Biohaven Pharmaceuticals, Inc.78$750
Lundbeck LLC31$705
Lilly USA, LLC35$551
Scilex Pharmaceuticals Inc.73$528
Pfizer26$521
UCB, Inc.26$439
Biohaven Pharmaceutical Holding Company Ltd.82$428
Impel Pharmaceuticals Inc.33$386
Upsher-smith Laboratories LLC18$283
Azurity Pharmaceuticals, Inc.12$217
Supernus Pharmaceuticals, Inc.12$193
AstraZeneca(2 entities)8$177
Impel Pharmaceuticals LLC9$174
Jazz Pharmaceuticals Inc.7$172
Arbor Pharmaceuticals, Inc.10$164
SK Life Science, Inc.5$123
Neurocrine Biosciences, Inc.6$112
Tanabe Pharma America, Inc.6$102
Eisai Inc.4$96
Catalyst Pharmaceuticals, Inc.4$92
CSL Behring3$72
Grifols USA, LLC3$68
Averitas Pharma Inc.3$62
Xeris Pharmaceuticals, Inc.3$60
Amneal Pharmaceuticals LLC4$57
Takeda Pharmaceuticals U.S.A., Inc.2$52
Redhill Biopharma Inc.2$48
Collegium Pharmaceutical, Inc.3$45
Boston Scientific1$38
Octapharma USA, Inc.2$32
Avanir Pharmaceuticals, Inc.1$27
Mirum Pharmaceuticals, Inc.1$22
Johnson & Johnson1$21
Otsuka America Pharmaceutical, Inc.1$20
Banner Life Sciences, LLC1$20
Biogen1$18
Novo Nordisk1$18
Acadia Pharmaceuticals Inc1$16
Avion Pharmaceuticals1$16
Bristol Myers Squibb1$15
Novocure Inc.1$12
Biodelivery Sciences International, Inc.1$12
GE HealthCare1$3

How this compares

$23,842 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York →

Medicare billing

Part B allowed, 2024
$53,013
Medicare patients
62
Services billed
6,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Amherst

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →